Megan Jones | Manager, Investor Relations |
Kevin Conroy | Chairman and Chief Executive Officer |
Jeff Elliott | Chief Financial Officer |
Mark Stenhouse | President of Cologuard |
Kim Popovits | Chairman and Chief Executive Officer, Genomic Health, Inc. |
Brad Cole | Chief Financial Officer, Genomic Health, Inc. |
Brian Weinstein | William Blair |
Doug Schenkel | Cowen & Company |
Derik de Bruin | Bank of America Merrill Lynch |
Brandon Couillard | Jefferies |
Patrick Donnelly | Goldman Sachs |
Tycho Peterson | JPMorgan |
Dan Brennan | UBS |
Catherine Schulte | Baird |
Puneet Souda | SVB Leerink |
Mark Massaro | Canaccord Genuity |
Bill Quirk | Piper Jaffray |
Good morning. My name is Chris, and I will be your conference operator today. At this time, I would like to welcome everyone to the Exact Sciences and Genomic Health Combination Second Quarter 2019 Earnings Results Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.